RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION

Abstract

The article provides an analysis of using medications in children’s oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic leukemia, etc.). According to АВС/VEN analysis, 79,9% of funds was spent on acquisition of 11 group A medications, 15,1% — on group B medications, 5% — on group C medications. Vital medications (V) accounted for 79,4%, essential medications (Е) — 14,7%, non-essential medications (N) — 5,9%. The authors examined the toxicity of vincristine depending on manufacturers.
Key words: children, malignant blood diseases, ABC/VEN analysis, vincristine, neurotoxicity.

(Pediatric Pharmacology. – 2010; 7(3):14-16)